UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 108

Sortiert nach

Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies

Annals of internal medicine, 2015-07, Vol.163 (2), p.127

2015

Link zum Volltext

Verfügbarkeit prüfen

Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio

JAMA oncology, 2017-12, Vol.3 (12), p.1692

2017

Link zum Volltext

Verfügbarkeit prüfen

Robust Alternatives to ANCOVA for Estimating the Treatment Effect via a Randomized Comparative Study

Journal of the American Statistical Association, 2019-10, Vol.114 (528), p.1854-1864

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficiency of Two Sample Tests via the Restricted Mean Survival Time for Analyzing Event Time Observations

Biometrics, 2018-06, Vol.74 (2), p.694-702

2018

Link zum Volltext

Verfügbarkeit prüfen

Detecting outlying trials in network meta-analysis

Statistics in medicine, 2015-08, Vol.34 (19), p.2695-2707

2015

Link zum Volltext

Verfügbarkeit prüfen

Enabling Eating Detection in a Free-living Environment: Integrative Engineering and Machine Learning Study

Journal of medical Internet research, 2022-03, Vol.24 (3), p.e27934-e27934

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluating and utilizing probability of study success in clinical development

Clinical trials (London, England), 2013-06, Vol.10 (3), p.407-413

2013

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Change in Adherence Status from 1 Year to the Next Among Patients with Type 2 Diabetes Mellitus on Oral Antidiabetes Drugs

Journal of managed care & specialty pharmacy, 2016-05, Vol.22 (5), p.467

2016

Link zum Volltext

Verfügbarkeit prüfen

Doubly robust estimation of the weighted average treatment effect for a target population

Statistics in medicine, 2019-02, Vol.38 (3), p.315-325

2019

Link zum Volltext

Verfügbarkeit prüfen

Learning Optimal Personalized Treatment Rules in Consideration of Benefit and Risk: With an Application to Treating Type 2 Diabetes Patients With Insulin Therapies

Journal of the American Statistical Association, 2018-01, Vol.113 (521), p.1-13

2018

Link zum Volltext

Verfügbarkeit prüfen

A randomized, cross-over comparison of preference between two reusable insulin pen devices in pen-naïve adults with diabetes

Current medical research and opinion, 2013-05, Vol.29 (5), p.465-473

2013

Link zum Volltext

Verfügbarkeit prüfen

Optimal individualized treatment rule for combination treatments under budget constraints

Journal of the Royal Statistical Society. Series B, Statistical methodology, 2024-07, Vol.86 (3), p.714-741

2024

Link zum Volltext

Verfügbarkeit prüfen

Multi-Armed Angle-Based Direct Learning for Estimating Optimal Individualized Treatment Rules With Various Outcomes

Journal of the American Statistical Association, 2020-04, Vol.115 (530), p.678-691

2020

Link zum Volltext

Verfügbarkeit prüfen

Model-Assisted Uniformly Honest Inference for Optimal Treatment Regimes in High Dimension

Journal of the American Statistical Association, 2023-01, Vol.118 (541), p.305-314

2023

Link zum Volltext

Verfügbarkeit prüfen

Multicategory Angle-Based Learning for Estimating Optimal Dynamic Treatment Regimes With Censored Data

Journal of the American Statistical Association, 2022-09, Vol.117 (539), p.1438-1451

2022

Link zum Volltext

Verfügbarkeit prüfen

Query-Augmented Active Metric Learning

Journal of the American Statistical Association, 2023-07, Vol.118 (543), p.1862-1875

2023

Link zum Volltext

Verfügbarkeit prüfen

Estimating individualized optimal combination therapies through outcome weighted deep learning algorithms

Statistics in medicine, 2018-11, Vol.37 (27), p.3869-3886

2018

Link zum Volltext

Verfügbarkeit prüfen

Controlling Cumulative Adverse Risk in Learning Optimal Dynamic Treatment Regimens

Journal of the American Statistical Association, 2023-12, p.1-12

2023

Link zum Volltext

Verfügbarkeit prüfen

High-Dimensional Cost-constrained Regression Via Nonconvex Optimization

Technometrics, 2022-01, Vol.64 (1), p.52-64

2022

Link zum Volltext

Verfügbarkeit prüfen

Estimate variable importance for recurrent event outcomes with an application to identify hypoglycemia risk factors

Statistics in medicine, 2015-08, Vol.34 (19), p.2743-2754

2015

Link zum Volltext

Verfügbarkeit prüfen

Risk controlled decision trees and random forests for precision Medicine

Statistics in medicine, 2022-02, Vol.41 (4), p.719-735

2022

Link zum Volltext

Verfügbarkeit prüfen

Bayesian indirect and mixed treatment comparisons across longitudinal time points

Statistics in medicine, 2013-07, Vol.32 (15), p.2613-2628

2013

Link zum Volltext

Verfügbarkeit prüfen

Deep Neural Networks Guided Ensemble Learning for Point Estimation

Statistics in biopharmaceutical research, 2024-04, Vol.16 (2), p.270-278

2024

Link zum Volltext

Verfügbarkeit prüfen

Bayesian isotonic regression dose-response model

Journal of biopharmaceutical statistics, 2017-09, Vol.27 (5), p.824-833

2017

Link zum Volltext

Verfügbarkeit prüfen

Estimating optimal treatment regimes via subgroup identification in randomized control trials and observational studies

Statistics in medicine, 2016-08, Vol.35 (19), p.3285-3302

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(89)
Life Sciences & Biomedicine
(62)
Humans
(56)
Mathematics
(51)
Physical Sciences
(50)
Statistics & Probability
(50)
Diabetes
(24)
Mathematical & Computational Biology
(21)
Algorithms
(20)
Diabetes Mellitus, Type 2 - Drug Therapy
(20)
Male
(18)
Aged
(17)
Female
(17)
Hypoglycemic Agents - Therapeutic Use
(17)
Clinical Trials
(16)
Medical Informatics
(16)
Statistics
(16)
Medicine, Research & Experimental
(15)
Middle Aged
(15)
Pharmacology & Pharmacy
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies

Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio

Robust Alternatives to ANCOVA for Estimating the Treatment Effect via a Randomized Comparative Study

Efficiency of Two Sample Tests via the Restricted Mean Survival Time for Analyzing Event Time Observations

Detecting outlying trials in network meta-analysis

Enabling Eating Detection in a Free-living Environment: Integrative Engineering and Machine Learning Study

Evaluating and utilizing probability of study success in clinical development

Predictors of Change in Adherence Status from 1 Year to the Next Among Patients with Type 2 Diabetes Mellitus on Oral Antidiabetes Drugs

Doubly robust estimation of the weighted average treatment effect for a target population

Learning Optimal Personalized Treatment Rules in Consideration of Benefit and Risk: With an Application to Treating Type 2 Diabetes Patients With Insulin Therapies

A randomized, cross-over comparison of preference between two reusable insulin pen devices in pen-naïve adults with diabetes

Optimal individualized treatment rule for combination treatments under budget constraints

Multi-Armed Angle-Based Direct Learning for Estimating Optimal Individualized Treatment Rules With Various Outcomes

Model-Assisted Uniformly Honest Inference for Optimal Treatment Regimes in High Dimension

Multicategory Angle-Based Learning for Estimating Optimal Dynamic Treatment Regimes With Censored Data

Query-Augmented Active Metric Learning

Estimating individualized optimal combination therapies through outcome weighted deep learning algorithms

Controlling Cumulative Adverse Risk in Learning Optimal Dynamic Treatment Regimens

High-Dimensional Cost-constrained Regression Via Nonconvex Optimization

Estimate variable importance for recurrent event outcomes with an application to identify hypoglycemia risk factors

Risk controlled decision trees and random forests for precision Medicine

Bayesian indirect and mixed treatment comparisons across longitudinal time points

Deep Neural Networks Guided Ensemble Learning for Point Estimation

Bayesian isotonic regression dose-response model

Estimating optimal treatment regimes via subgroup identification in randomized control trials and observational studies

Suchergebnisse filtern